Working... Menu

Screening for Glaucoma in Namil Area, South Korea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00727168
Recruitment Status : Completed
First Posted : August 1, 2008
Last Update Posted : August 4, 2008
Information provided by:
Korean Glaucoma Society

Brief Summary:
The purpose of this study is to study the prevalence of glaucoma in Korea, the investigators selected Namil area in Geumsan city, located in central Korea. The residents aged over 40 in this area are to be recruited to full ophthalmologic examination to detect and classify the glaucoma.

Condition or disease
Glaucoma Intraocular Pressure Optic Nerve Head Visual Field

Detailed Description:
Screening includes following examinations; Questionaire and Consent form, Visual acuity test, Auto-refraction, IOL Master measurement, Pachymetry, FDT Perimetry, Fundus Photography, Slit lamp examination, Goldmann applanation Tonometry, Gonioscopy, and Binocular optic disc evaluation. For the cases showing any abnormality in FDT perimetry, optic disc morphology, or intraocular pressure, Humphrey automated visual field test is to be performed as an extended examination. Finally, optic nerve head evaluation by OCT or GDx analyzer is to be used as a confirmation test, as well as additional Humphrey visual field test.

Layout table for study information
Study Type : Observational
Actual Enrollment : 1532 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Epidemiologic Study for the Prevalence of Glaucoma in Namil Area, Geumsan City, South Korea
Study Start Date : November 2007
Actual Primary Completion Date : February 2008
Actual Study Completion Date : February 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma

Primary Outcome Measures :
  1. Prevalence of glaucoma in Namil area [ Time Frame: cross-sectional ]

Secondary Outcome Measures :
  1. Clinical factors associated with the glaucoma [ Time Frame: cross-sectional ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
All residents aged over 40 in Namil area in Geumsan city

Inclusion Criteria:

  • All residents aged over 40 in Namil area

Exclusion Criteria:

  • Individuals registered but not actually living in this area

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00727168

Layout table for location information
Korea, Republic of
Yongdong Severance Hospital
Seoul, Korea, Republic of, 135-720
Sponsors and Collaborators
Korean Glaucoma Society
Layout table for investigator information
Principal Investigator: Gong-je Seong, MD, PhD Korean Glaucoma Society

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Gong-je Seong, president, Korean Glaucoma Society Identifier: NCT00727168     History of Changes
Other Study ID Numbers: CNUH81510-9701
First Posted: August 1, 2008    Key Record Dates
Last Update Posted: August 4, 2008
Last Verified: August 2008

Keywords provided by Korean Glaucoma Society:
prevalence study

Additional relevant MeSH terms:
Layout table for MeSH terms
Ocular Hypertension
Eye Diseases